Medical supervision matters most for people with diabetes, cancer history, abnormal growth hormone or IGF-1 levels, thyroid concerns, heart disease, kidney issues, or unexplained swelling
Wegovy contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines
What this means for a CJC-1295 protocol running weeks to months at GH-secretagogue doses: the IGF-1 elevation involved (roughly 1.5 to 3-fold above baseline per Teichman's dosing data) is meaningfully smaller in magnitude and duration than the decades-long pathological exposure seen in acromegaly
Efficacy of metformin therapy in patients with cancer: a meta-analysis of 22 randomised controlled trials
How long will it take to see results after switching to tirzepatide
To overcome the short half-life and frequent subcutaneous administration of pramlintide, new amylin receptor agonists like cagrilintide have been developed